Battery Additives Market By Type (Electrolyte additive, Conductive additive, Cathode additives, Anode additives, Others) , By Application (Lead-acid batteries, Graphene batteries, Lithium-ion batteries, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The battery additives market was valued at $1.7 billion in 2023, and is projected t%li%reach $3.9 billion by 2033, growing at a CAGR of 8.5% from 2024 t%li%2033.
Battery additives refer t%li%materials that are added t%li%batteries in minute quantities t%li%enhance the performance, cycleability, safety, thermal stability, and various physical properties of batteries. Addition of chemical additives prolongs the service life of batteries by dissolving the lead sulfate buildup on lead plates and internal connectors, thereby improving the overall battery performance. Suitable battery additives available in the market include caustic soda, EDTA—a crystalline acid—and Epsom salt. These additives are cost-effective, readily available, and thus serve as an ideal solution t%li%extend the service of aging batteries.
The key driving factors of the global battery additives market include increase in penetration of portable electronics such as such as smartphones, laptops, tablets, and wearables. According t%li%the estimates of Statista approximately 6.7 billion smartphone subscriptions were registered worldwide in 2023 among a global population of around 7.4 billion. Moreover, surge in adoption of electric vehicles significantly contributes toward the growth of the global market. According t%li%the International Energy Agency, a Paris-based autonomous intergovernmental organization, over 3 million electric vehicles were sold in the first quarter of 2024, around 25% higher as compared t%li%2023. This number is estimated t%li%reach 17 million by the end of 2024, exhibiting a 20% year-on-year increase. These applications require high-performance batteries, which, in turn, propel the demand for battery additives, as they play a crucial role in improving battery efficiency and enhancing the longevity of electronic devices. Furthermore, surge in demand for biodegradable additives acts as the primary driver of the global battery additives market. Many smart devices are now being integrated with solid-state batteries, which reduce the risks of leakage and combustion as well as offer superior safety by replacing the liquid electrolyte. Solid-state batteries further prevent the formation of dendrite, which are needle-like structures that lead t%li%short-circuit in batteries. Some solid electrolytes are made from nontoxic and abundantly available materials, which make them sustainable and cost-efficient. However, chemical additives cannot replace the active material of the batteries, which necessitates battery replacement. This is attributed t%li%the fact that batteries are maintenance-prone and need regular replacement, thus lowering the dependence on additives t%li%prolong battery life. This acts as a key deterrent factor of the global battery additives market. Moreover, the market growth is significantly hampered by improper disposal practices of batteries that can lead t%li%several environmental and health issues due t%li%toxicity of chemical additives. On the contrary, implementation of supportive government initiatives for proper battery disposal is expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. For instance, the Government of India has implemented the Hazardous Waste Management Rules, 2016, issued under the Environmental Protection Act (EPA) of 1986, which ensure strict adherence t%li%the disposal and recycling of lead-acid batteries in India. Furthermore, manufacturers are focusing on exploring the potential of bio-based additives such as cellulose-based electrolytes and ionic liquids derived from amin%li%acids and other biological precursors t%li%achieve sustainability goals, which is expected t%li%open new avenues for the expansion of the global market during the forecast period.
The global battery additive market is segmented int%li%type, application, and region. By type, the market is classified int%li%electrolyte additive, conductive additive, cathode additives, anode additives, and others. On the basis of application, it is categorized int%li%lead-acid batteries, graphene batteries, lithium-ion batteries, and others. Region wise, the market is studied across areas such as North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the electrolyte additive segment is anticipated t%li%exhibit the leading position by 2033.
Depending on application, the lithium-ion batteries segment is projected t%li%dominate the market during the forecast period.
Region wise, battery additives are expected t%li%gain high prominence in Asia-Pacific in the coming years.
Competition Analysis
Competitive analysis and profiles of the major players in the global battery additives market include BASF SE, Ascend Performance Materials, ALTANA, Harsha Industries, Arkema, Cabot, 3M, Imerys S.A., Hammond Group, Inc., and SGL Carbon. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
By Type
Battery additives refer t%li%materials that are added t%li%batteries in minute quantities t%li%enhance the performance, cycleability, safety, thermal stability, and various physical properties of batteries. Addition of chemical additives prolongs the service life of batteries by dissolving the lead sulfate buildup on lead plates and internal connectors, thereby improving the overall battery performance. Suitable battery additives available in the market include caustic soda, EDTA—a crystalline acid—and Epsom salt. These additives are cost-effective, readily available, and thus serve as an ideal solution t%li%extend the service of aging batteries.
The key driving factors of the global battery additives market include increase in penetration of portable electronics such as such as smartphones, laptops, tablets, and wearables. According t%li%the estimates of Statista approximately 6.7 billion smartphone subscriptions were registered worldwide in 2023 among a global population of around 7.4 billion. Moreover, surge in adoption of electric vehicles significantly contributes toward the growth of the global market. According t%li%the International Energy Agency, a Paris-based autonomous intergovernmental organization, over 3 million electric vehicles were sold in the first quarter of 2024, around 25% higher as compared t%li%2023. This number is estimated t%li%reach 17 million by the end of 2024, exhibiting a 20% year-on-year increase. These applications require high-performance batteries, which, in turn, propel the demand for battery additives, as they play a crucial role in improving battery efficiency and enhancing the longevity of electronic devices. Furthermore, surge in demand for biodegradable additives acts as the primary driver of the global battery additives market. Many smart devices are now being integrated with solid-state batteries, which reduce the risks of leakage and combustion as well as offer superior safety by replacing the liquid electrolyte. Solid-state batteries further prevent the formation of dendrite, which are needle-like structures that lead t%li%short-circuit in batteries. Some solid electrolytes are made from nontoxic and abundantly available materials, which make them sustainable and cost-efficient. However, chemical additives cannot replace the active material of the batteries, which necessitates battery replacement. This is attributed t%li%the fact that batteries are maintenance-prone and need regular replacement, thus lowering the dependence on additives t%li%prolong battery life. This acts as a key deterrent factor of the global battery additives market. Moreover, the market growth is significantly hampered by improper disposal practices of batteries that can lead t%li%several environmental and health issues due t%li%toxicity of chemical additives. On the contrary, implementation of supportive government initiatives for proper battery disposal is expected t%li%offer remunerative opportunities for the expansion of the global market during the forecast period. For instance, the Government of India has implemented the Hazardous Waste Management Rules, 2016, issued under the Environmental Protection Act (EPA) of 1986, which ensure strict adherence t%li%the disposal and recycling of lead-acid batteries in India. Furthermore, manufacturers are focusing on exploring the potential of bio-based additives such as cellulose-based electrolytes and ionic liquids derived from amin%li%acids and other biological precursors t%li%achieve sustainability goals, which is expected t%li%open new avenues for the expansion of the global market during the forecast period.
The global battery additive market is segmented int%li%type, application, and region. By type, the market is classified int%li%electrolyte additive, conductive additive, cathode additives, anode additives, and others. On the basis of application, it is categorized int%li%lead-acid batteries, graphene batteries, lithium-ion batteries, and others. Region wise, the market is studied across areas such as North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the electrolyte additive segment is anticipated t%li%exhibit the leading position by 2033.
Depending on application, the lithium-ion batteries segment is projected t%li%dominate the market during the forecast period.
Region wise, battery additives are expected t%li%gain high prominence in Asia-Pacific in the coming years.
Competition Analysis
Competitive analysis and profiles of the major players in the global battery additives market include BASF SE, Ascend Performance Materials, ALTANA, Harsha Industries, Arkema, Cabot, 3M, Imerys S.A., Hammond Group, Inc., and SGL Carbon. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%strengthen their foothold in the competitive market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Manufacturing Capacity
- Investment Opportunities
- Upcoming/New Entrant by Regions
- Technology Trend Analysis
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Import Export Analysis/Data
- SWOT Analysis
- Volume Market Size and Forecast
By Type
- Electrolyte additive
- Conductive additive
- Cathode additives
- Anode additives
- Others
- Lead-acid batteries
- Graphene batteries
- Lithium-ion batteries
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- BASF SE
- Ascend Performance Materials
- ALTANA
- Harsha Industries
- Arkema
- Cabot
- 3M
- Imerys S.A.
- Hammond Group, Inc.
- SGL Carbon
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: GENOMICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Consumables And Reagent
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Instruments, Systems And Software
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Sequencing
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. PCR
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Flow Cytometry
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Microarray
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: GENOMICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Functional Genomics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Epigenomics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Pathway Analysis
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Biomarker Discovery
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: GENOMICS MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Clinical Research
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Academic And Government Institutions
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Hospitals And Clinics
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Pharmaceutical And Biotechnology Companies
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
7.6. Others
7.6.1. Key Market Trends, Growth Factors and Opportunities
7.6.2. Market Size and Forecast, By Region
7.6.3. Market Share Analysis, By Country
CHAPTER 8: GENOMICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Genomics Market
8.2.7.1. Market Size and Forecast, By Product
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Genomics Market
8.2.8.1. Market Size and Forecast, By Product
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Genomics Market
8.2.9.1. Market Size and Forecast, By Product
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Genomics Market
8.3.7.1. Market Size and Forecast, By Product
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Genomics Market
8.3.8.1. Market Size and Forecast, By Product
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Genomics Market
8.3.9.1. Market Size and Forecast, By Product
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Genomics Market
8.3.10.1. Market Size and Forecast, By Product
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Genomics Market
8.3.11.1. Market Size and Forecast, By Product
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest of Europe Genomics Market
8.3.12.1. Market Size and Forecast, By Product
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Genomics Market
8.4.7.1. Market Size and Forecast, By Product
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Genomics Market
8.4.8.1. Market Size and Forecast, By Product
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Genomics Market
8.4.9.1. Market Size and Forecast, By Product
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Genomics Market
8.4.10.1. Market Size and Forecast, By Product
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Genomics Market
8.4.11.1. Market Size and Forecast, By Product
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Genomics Market
8.4.12.1. Market Size and Forecast, By Product
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Genomics Market
8.5.7.1. Market Size and Forecast, By Product
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Genomics Market
8.5.8.1. Market Size and Forecast, By Product
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Genomics Market
8.5.9.1. Market Size and Forecast, By Product
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. UAE Genomics Market
8.5.10.1. Market Size and Forecast, By Product
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
8.5.11. Rest of LAMEA Genomics Market
8.5.11.1. Market Size and Forecast, By Product
8.5.11.2. Market Size and Forecast, By Technology
8.5.11.3. Market Size and Forecast, By Application
8.5.11.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Color Genomics, Inc.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. BGI Genomics
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Danaher Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Eppendorf AG
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Eurofins Scientific SE
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. F. Hoffmann-La Roche Ltd.
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. GE Healthcare
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Illumina, Inc.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Bio-Rad Laboratories, Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: GENOMICS MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Consumables And Reagent
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Services
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Instruments, Systems And Software
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY
5.1. Market Overview
5.1.1 Market Size and Forecast, By Technology
5.2. Sequencing
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. PCR
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Flow Cytometry
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Microarray
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: GENOMICS MARKET, BY APPLICATION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Application
6.2. Functional Genomics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Epigenomics
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Pathway Analysis
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Biomarker Discovery
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
6.6. Others
6.6.1. Key Market Trends, Growth Factors and Opportunities
6.6.2. Market Size and Forecast, By Region
6.6.3. Market Share Analysis, By Country
CHAPTER 7: GENOMICS MARKET, BY END USER
7.1. Market Overview
7.1.1 Market Size and Forecast, By End User
7.2. Clinical Research
7.2.1. Key Market Trends, Growth Factors and Opportunities
7.2.2. Market Size and Forecast, By Region
7.2.3. Market Share Analysis, By Country
7.3. Academic And Government Institutions
7.3.1. Key Market Trends, Growth Factors and Opportunities
7.3.2. Market Size and Forecast, By Region
7.3.3. Market Share Analysis, By Country
7.4. Hospitals And Clinics
7.4.1. Key Market Trends, Growth Factors and Opportunities
7.4.2. Market Size and Forecast, By Region
7.4.3. Market Share Analysis, By Country
7.5. Pharmaceutical And Biotechnology Companies
7.5.1. Key Market Trends, Growth Factors and Opportunities
7.5.2. Market Size and Forecast, By Region
7.5.3. Market Share Analysis, By Country
7.6. Others
7.6.1. Key Market Trends, Growth Factors and Opportunities
7.6.2. Market Size and Forecast, By Region
7.6.3. Market Share Analysis, By Country
CHAPTER 8: GENOMICS MARKET, BY REGION
8.1. Market Overview
8.1.1 Market Size and Forecast, By Region
8.2. North America
8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, By Product
8.2.3. Market Size and Forecast, By Technology
8.2.4. Market Size and Forecast, By Application
8.2.5. Market Size and Forecast, By End User
8.2.6. Market Size and Forecast, By Country
8.2.7. U.S. Genomics Market
8.2.7.1. Market Size and Forecast, By Product
8.2.7.2. Market Size and Forecast, By Technology
8.2.7.3. Market Size and Forecast, By Application
8.2.7.4. Market Size and Forecast, By End User
8.2.8. Canada Genomics Market
8.2.8.1. Market Size and Forecast, By Product
8.2.8.2. Market Size and Forecast, By Technology
8.2.8.3. Market Size and Forecast, By Application
8.2.8.4. Market Size and Forecast, By End User
8.2.9. Mexico Genomics Market
8.2.9.1. Market Size and Forecast, By Product
8.2.9.2. Market Size and Forecast, By Technology
8.2.9.3. Market Size and Forecast, By Application
8.2.9.4. Market Size and Forecast, By End User
8.3. Europe
8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, By Product
8.3.3. Market Size and Forecast, By Technology
8.3.4. Market Size and Forecast, By Application
8.3.5. Market Size and Forecast, By End User
8.3.6. Market Size and Forecast, By Country
8.3.7. France Genomics Market
8.3.7.1. Market Size and Forecast, By Product
8.3.7.2. Market Size and Forecast, By Technology
8.3.7.3. Market Size and Forecast, By Application
8.3.7.4. Market Size and Forecast, By End User
8.3.8. Germany Genomics Market
8.3.8.1. Market Size and Forecast, By Product
8.3.8.2. Market Size and Forecast, By Technology
8.3.8.3. Market Size and Forecast, By Application
8.3.8.4. Market Size and Forecast, By End User
8.3.9. Italy Genomics Market
8.3.9.1. Market Size and Forecast, By Product
8.3.9.2. Market Size and Forecast, By Technology
8.3.9.3. Market Size and Forecast, By Application
8.3.9.4. Market Size and Forecast, By End User
8.3.10. Spain Genomics Market
8.3.10.1. Market Size and Forecast, By Product
8.3.10.2. Market Size and Forecast, By Technology
8.3.10.3. Market Size and Forecast, By Application
8.3.10.4. Market Size and Forecast, By End User
8.3.11. UK Genomics Market
8.3.11.1. Market Size and Forecast, By Product
8.3.11.2. Market Size and Forecast, By Technology
8.3.11.3. Market Size and Forecast, By Application
8.3.11.4. Market Size and Forecast, By End User
8.3.12. Rest of Europe Genomics Market
8.3.12.1. Market Size and Forecast, By Product
8.3.12.2. Market Size and Forecast, By Technology
8.3.12.3. Market Size and Forecast, By Application
8.3.12.4. Market Size and Forecast, By End User
8.4. Asia-Pacific
8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, By Product
8.4.3. Market Size and Forecast, By Technology
8.4.4. Market Size and Forecast, By Application
8.4.5. Market Size and Forecast, By End User
8.4.6. Market Size and Forecast, By Country
8.4.7. China Genomics Market
8.4.7.1. Market Size and Forecast, By Product
8.4.7.2. Market Size and Forecast, By Technology
8.4.7.3. Market Size and Forecast, By Application
8.4.7.4. Market Size and Forecast, By End User
8.4.8. Japan Genomics Market
8.4.8.1. Market Size and Forecast, By Product
8.4.8.2. Market Size and Forecast, By Technology
8.4.8.3. Market Size and Forecast, By Application
8.4.8.4. Market Size and Forecast, By End User
8.4.9. India Genomics Market
8.4.9.1. Market Size and Forecast, By Product
8.4.9.2. Market Size and Forecast, By Technology
8.4.9.3. Market Size and Forecast, By Application
8.4.9.4. Market Size and Forecast, By End User
8.4.10. South Korea Genomics Market
8.4.10.1. Market Size and Forecast, By Product
8.4.10.2. Market Size and Forecast, By Technology
8.4.10.3. Market Size and Forecast, By Application
8.4.10.4. Market Size and Forecast, By End User
8.4.11. Australia Genomics Market
8.4.11.1. Market Size and Forecast, By Product
8.4.11.2. Market Size and Forecast, By Technology
8.4.11.3. Market Size and Forecast, By Application
8.4.11.4. Market Size and Forecast, By End User
8.4.12. Rest of Asia-Pacific Genomics Market
8.4.12.1. Market Size and Forecast, By Product
8.4.12.2. Market Size and Forecast, By Technology
8.4.12.3. Market Size and Forecast, By Application
8.4.12.4. Market Size and Forecast, By End User
8.5. LAMEA
8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, By Product
8.5.3. Market Size and Forecast, By Technology
8.5.4. Market Size and Forecast, By Application
8.5.5. Market Size and Forecast, By End User
8.5.6. Market Size and Forecast, By Country
8.5.7. Brazil Genomics Market
8.5.7.1. Market Size and Forecast, By Product
8.5.7.2. Market Size and Forecast, By Technology
8.5.7.3. Market Size and Forecast, By Application
8.5.7.4. Market Size and Forecast, By End User
8.5.8. South Africa Genomics Market
8.5.8.1. Market Size and Forecast, By Product
8.5.8.2. Market Size and Forecast, By Technology
8.5.8.3. Market Size and Forecast, By Application
8.5.8.4. Market Size and Forecast, By End User
8.5.9. Saudi Arabia Genomics Market
8.5.9.1. Market Size and Forecast, By Product
8.5.9.2. Market Size and Forecast, By Technology
8.5.9.3. Market Size and Forecast, By Application
8.5.9.4. Market Size and Forecast, By End User
8.5.10. UAE Genomics Market
8.5.10.1. Market Size and Forecast, By Product
8.5.10.2. Market Size and Forecast, By Technology
8.5.10.3. Market Size and Forecast, By Application
8.5.10.4. Market Size and Forecast, By End User
8.5.11. Rest of LAMEA Genomics Market
8.5.11.1. Market Size and Forecast, By Product
8.5.11.2. Market Size and Forecast, By Technology
8.5.11.3. Market Size and Forecast, By Application
8.5.11.4. Market Size and Forecast, By End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Color Genomics, Inc.
10.1.1. Company Overview
10.1.2. Key Executives
10.1.3. Company Snapshot
10.1.4. Operating Business Segments
10.1.5. Product Portfolio
10.1.6. Business Performance
10.1.7. Key Strategic Moves and Developments
10.2. BGI Genomics
10.2.1. Company Overview
10.2.2. Key Executives
10.2.3. Company Snapshot
10.2.4. Operating Business Segments
10.2.5. Product Portfolio
10.2.6. Business Performance
10.2.7. Key Strategic Moves and Developments
10.3. Agilent Technologies
10.3.1. Company Overview
10.3.2. Key Executives
10.3.3. Company Snapshot
10.3.4. Operating Business Segments
10.3.5. Product Portfolio
10.3.6. Business Performance
10.3.7. Key Strategic Moves and Developments
10.4. Danaher Corporation
10.4.1. Company Overview
10.4.2. Key Executives
10.4.3. Company Snapshot
10.4.4. Operating Business Segments
10.4.5. Product Portfolio
10.4.6. Business Performance
10.4.7. Key Strategic Moves and Developments
10.5. Eppendorf AG
10.5.1. Company Overview
10.5.2. Key Executives
10.5.3. Company Snapshot
10.5.4. Operating Business Segments
10.5.5. Product Portfolio
10.5.6. Business Performance
10.5.7. Key Strategic Moves and Developments
10.6. Eurofins Scientific SE
10.6.1. Company Overview
10.6.2. Key Executives
10.6.3. Company Snapshot
10.6.4. Operating Business Segments
10.6.5. Product Portfolio
10.6.6. Business Performance
10.6.7. Key Strategic Moves and Developments
10.7. F. Hoffmann-La Roche Ltd.
10.7.1. Company Overview
10.7.2. Key Executives
10.7.3. Company Snapshot
10.7.4. Operating Business Segments
10.7.5. Product Portfolio
10.7.6. Business Performance
10.7.7. Key Strategic Moves and Developments
10.8. GE Healthcare
10.8.1. Company Overview
10.8.2. Key Executives
10.8.3. Company Snapshot
10.8.4. Operating Business Segments
10.8.5. Product Portfolio
10.8.6. Business Performance
10.8.7. Key Strategic Moves and Developments
10.9. Illumina, Inc.
10.9.1. Company Overview
10.9.2. Key Executives
10.9.3. Company Snapshot
10.9.4. Operating Business Segments
10.9.5. Product Portfolio
10.9.6. Business Performance
10.9.7. Key Strategic Moves and Developments
10.10. Bio-Rad Laboratories, Inc.
10.10.1. Company Overview
10.10.2. Key Executives
10.10.3. Company Snapshot
10.10.4. Operating Business Segments
10.10.5. Product Portfolio
10.10.6. Business Performance
10.10.7. Key Strategic Moves and Developments
